CL2016002992A1 - Combinación, composición y método de administración de la combinación o composición a animales - Google Patents

Combinación, composición y método de administración de la combinación o composición a animales

Info

Publication number
CL2016002992A1
CL2016002992A1 CL2016002992A CL2016002992A CL2016002992A1 CL 2016002992 A1 CL2016002992 A1 CL 2016002992A1 CL 2016002992 A CL2016002992 A CL 2016002992A CL 2016002992 A CL2016002992 A CL 2016002992A CL 2016002992 A1 CL2016002992 A1 CL 2016002992A1
Authority
CL
Chile
Prior art keywords
composition
combination
animals
administration
yucca
Prior art date
Application number
CL2016002992A
Other languages
English (en)
Inventor
Kenneth W Bafundo
A Bruce Johnson
David Calabotta
Wendell Knehans
Original Assignee
Phibro Animal Health Corporation
Desert King Int Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phibro Animal Health Corporation, Desert King Int Llc filed Critical Phibro Animal Health Corporation
Publication of CL2016002992A1 publication Critical patent/CL2016002992A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)

Abstract

Composición que comprende Quillaja saponaria y Yucca schidigera junto con una segunda composición que comprende un agente antimicrobiano, un antibiótico, un agente anticoccidial distinto del extracto de Yucca s. o combinaciones de los mismos, formulada para animales de granja, y especificaciones de dicha composición, el método para su elaboración, así como al uso terapéutico de la misma.
CL2016002992A 2014-05-23 2016-11-22 Combinación, composición y método de administración de la combinación o composición a animales CL2016002992A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462002527P 2014-05-23 2014-05-23

Publications (1)

Publication Number Publication Date
CL2016002992A1 true CL2016002992A1 (es) 2017-05-19

Family

ID=53366304

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016002992A CL2016002992A1 (es) 2014-05-23 2016-11-22 Combinación, composición y método de administración de la combinación o composición a animales

Country Status (18)

Country Link
US (4) US10413581B2 (es)
EP (1) EP3145522B1 (es)
JP (2) JP6869177B2 (es)
KR (1) KR20170008850A (es)
CN (1) CN106659787A (es)
AU (2) AU2015263877B2 (es)
BR (1) BR112016027335B1 (es)
CA (1) CA2949965A1 (es)
CL (1) CL2016002992A1 (es)
ES (1) ES2856207T3 (es)
IL (1) IL249061B (es)
MX (1) MX381845B (es)
MY (1) MY181854A (es)
PH (1) PH12016502323A1 (es)
PL (1) PL3145522T3 (es)
RU (1) RU2707076C2 (es)
WO (1) WO2015179840A1 (es)
ZA (1) ZA201608077B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6045895B2 (ja) 2012-10-01 2016-12-14 株式会社トプコン 眼科観察装置
US11238056B2 (en) 2013-10-28 2022-02-01 Microsoft Technology Licensing, Llc Enhancing search results with social labels
US11645289B2 (en) 2014-02-04 2023-05-09 Microsoft Technology Licensing, Llc Ranking enterprise graph queries
WO2015123456A1 (en) 2014-02-12 2015-08-20 OmniGen Research, L.L.C. Composition and method for promoting reduction of heat stress in animals
US9870432B2 (en) 2014-02-24 2018-01-16 Microsoft Technology Licensing, Llc Persisted enterprise graph queries
US11657060B2 (en) 2014-02-27 2023-05-23 Microsoft Technology Licensing, Llc Utilizing interactivity signals to generate relationships and promote content
US10757201B2 (en) 2014-03-01 2020-08-25 Microsoft Technology Licensing, Llc Document and content feed
US10255563B2 (en) 2014-03-03 2019-04-09 Microsoft Technology Licensing, Llc Aggregating enterprise graph content around user-generated topics
US10394827B2 (en) 2014-03-03 2019-08-27 Microsoft Technology Licensing, Llc Discovering enterprise content based on implicit and explicit signals
US10169457B2 (en) 2014-03-03 2019-01-01 Microsoft Technology Licensing, Llc Displaying and posting aggregated social activity on a piece of enterprise content
KR20170008850A (ko) * 2014-05-23 2017-01-24 피브로-애니멀 헬스 코포레이션 배합물, 조성물, 및 배합물 또는 조성물의 동물로의 투여 방법
US10061826B2 (en) * 2014-09-05 2018-08-28 Microsoft Technology Licensing, Llc. Distant content discovery
WO2017044832A1 (en) * 2015-09-09 2017-03-16 Omnigen Research, Llc A composition and/or combination for aquaculture
NO345485B1 (en) 2016-07-29 2021-03-01 Saponin Res Center S A Use of Quillaja saponaria extracts for the prevention and control of bacterial infections in fish and compositions comprising such extracts
WO2018018171A1 (es) 2016-07-29 2018-02-01 Saponin Research Center S.A. Uso de extractos de quillaja saponaria para la prevención y control de infecciones virales en peces
WO2018215389A1 (en) 2017-05-22 2018-11-29 F. Hoffmann-La Roche Ag Therapeutic compounds and compositions, and methods of use thereof
CN107535727A (zh) * 2017-10-29 2018-01-05 镇江龙润生态农业发展有限公司 一种含有中草药的用于肉鸡无抗生态养殖的饲料添加剂
WO2019147799A1 (en) 2018-01-24 2019-08-01 Omnigen Research, Llc Bacillus combination for administration to animals
CN108553640A (zh) * 2018-06-13 2018-09-21 佛山市正典生物技术有限公司 一种鸡球虫病弱毒活疫苗及其制备方法和应用
US20230263815A1 (en) 2020-06-19 2023-08-24 Kimberly-Clark Worldwide, Inc. Saponin containing extracts prepared from hesperaloe useful in the treatment of non-human animals
CA3182453A1 (en) * 2020-06-19 2021-12-23 Ning Wei Saponin containing extracts prepared from hesperaloe useful in the treatment of non-human animals
WO2022031753A1 (en) * 2020-08-03 2022-02-10 Robert Scott Foote Supplement for livestock
KR102718991B1 (ko) * 2020-09-25 2024-10-16 씨제이제일제당 (주) 스틸벤계 화합물을 포함하는 항콕시듐증 조성물 및 이의 용도
US20240148671A1 (en) * 2021-03-10 2024-05-09 Cornell University Methods for improving poultry health
CN113057141A (zh) * 2021-05-10 2021-07-02 天津农学院 一种提高蛋鸡蛋黄中卵磷脂含量的饲喂方法
ES2932416B2 (es) * 2021-07-07 2023-09-28 Biovet S A Aditivo para animales que contiene saponinas, compuestos fenolicos y p-cimenol, y procedimiento para su obtencion
WO2023163884A1 (en) * 2022-02-22 2023-08-31 Phibro Animal Health Corporation Liquid formulation comprising yucca and quillaja for administration to animals
WO2024156767A1 (en) * 2023-01-25 2024-08-02 Nutreco Nederland B.V. Method of feeding (pre)ruminants
WO2025085377A1 (en) * 2023-10-16 2025-04-24 Zoetis Services Llc Use of zoalene in livestock

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07107923A (ja) 1993-10-13 1995-04-25 Taiyo Kagaku Co Ltd 飼料用組成物
JP3422834B2 (ja) * 1994-02-09 2003-06-30 日本農産工業株式会社 飼料添加剤
JP3623994B2 (ja) 1994-11-05 2005-02-23 太陽化学株式会社 甲殻類の感染症抑制飼料組成物
JPH09224585A (ja) * 1996-02-26 1997-09-02 F Hoffmann La Roche Ag ニワトリにおける成長促進
TWI223595B (en) 1999-09-07 2004-11-11 Distributors Proc Inc Steroidal sapogenins for the control of coccidiosis in animals
DE19952360A1 (de) 1999-10-30 2001-05-17 Becker Klaus Wolfgang Verwendung von Saponinen und/oder Saponin-Derivaten als Wirkstoff bei der Aufzucht und Mast von Fischen und Krustentieren, deren Einsatz als Futtermittelzusatz sowie Futtermittel, enthaltend diese Futtermittelzusätze
AU2002219348B2 (en) 2001-01-08 2006-11-16 Pathway Intermediates Ltd Autoinducer compounds and their uses
US20040096527A1 (en) * 2001-02-27 2004-05-20 Jin-Hyuck Jang Compositions for lowering serum cholesterol level
ZA200400479B (en) 2001-07-06 2006-05-31 Abic Biolog Lab Teva Nucleic acids encoding recombinant 56 a 82 KDA antigens from gametocytes of Eimeria maxima and their use
JP3995541B2 (ja) * 2002-06-28 2007-10-24 株式会社ゲン・コーポレーション 抗鶏コクシジウム症組成物
AU2003246674B2 (en) * 2002-07-10 2008-08-14 Intervet International B.V. Immunogenic composition comprising a fusion protein and a saponin adjuvant
US7416742B2 (en) * 2004-06-16 2008-08-26 Sartec Corporation Methods and compositions for controlling microorganism populations in the digestive system of animals
AU2007322424B2 (en) * 2006-11-20 2013-05-16 Duecom Use of lipid containing particles comprising quillaja saponins for the treatment of cancer
TW201010719A (en) * 2008-08-19 2010-03-16 Wyeth Corp Immunological composition
US20100150958A1 (en) * 2008-12-15 2010-06-17 Vectogen Pty Ltd. Methods and Compositions for Use of a Coccidiosis Vaccine
ES2386474B1 (es) * 2011-01-21 2013-07-09 Norel, Sa Aditivos para alimentación animal.
KR20170008850A (ko) * 2014-05-23 2017-01-24 피브로-애니멀 헬스 코포레이션 배합물, 조성물, 및 배합물 또는 조성물의 동물로의 투여 방법
WO2019147799A1 (en) * 2018-01-24 2019-08-01 Omnigen Research, Llc Bacillus combination for administration to animals

Also Published As

Publication number Publication date
AU2021202307A1 (en) 2021-05-13
US20250152654A1 (en) 2025-05-15
JP6869177B2 (ja) 2021-05-12
JP2017517570A (ja) 2017-06-29
JP2020090502A (ja) 2020-06-11
IL249061A0 (en) 2017-01-31
US20170072002A1 (en) 2017-03-16
US12201666B2 (en) 2025-01-21
RU2016149801A3 (es) 2018-11-14
US10912810B2 (en) 2021-02-09
AU2015263877A1 (en) 2017-01-12
US20210113647A1 (en) 2021-04-22
PL3145522T3 (pl) 2021-06-14
AU2021202307B2 (en) 2022-06-30
KR20170008850A (ko) 2017-01-24
CA2949965A1 (en) 2015-11-26
WO2015179840A1 (en) 2015-11-26
MY181854A (en) 2021-01-11
RU2016149801A (ru) 2018-06-25
ZA201608077B (en) 2020-01-29
ES2856207T3 (es) 2021-09-27
PH12016502323A1 (en) 2017-02-06
US20190350998A1 (en) 2019-11-21
EP3145522A1 (en) 2017-03-29
AU2015263877B2 (en) 2021-01-21
EP3145522B1 (en) 2020-12-23
US10413581B2 (en) 2019-09-17
MX381845B (es) 2025-03-13
MX2016015326A (es) 2017-05-30
RU2707076C2 (ru) 2019-11-22
CN106659787A (zh) 2017-05-10
IL249061B (en) 2020-05-31
BR112016027335B1 (pt) 2021-06-08

Similar Documents

Publication Publication Date Title
CL2016002992A1 (es) Combinación, composición y método de administración de la combinación o composición a animales
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
CL2015002710A1 (es) Composiciones de arni contra el componente c5 del complemento y métodos para su uso.
MX2019005379A (es) Derivado de pirazolo-heteroarilo, metodo de preparacion y uso medico del mismo.
CL2018000299A1 (es) Composiciones con potenciadores de impregnacion para el suministro de fármacos.
MX2017007829A (es) Composicion antimicrobiana.
CR20150455A (es) Imidazopiridazinas sustituidas
CL2016000009A1 (es) Tratamiento de rosacea papulopustular con ivermectina.
NI201700078A (es) Pirazolpiridinaminas
NI201600006A (es) Pirazolo-piridinaminas sustituidas
CL2015001446A1 (es) Procedimiento de preparación de albumina humana con nivel de oxigeno disuelto reducido.
DOP2016000118A (es) Tienopirimidinas como inhibidores mknk1 y mknk2
DOP2015000298A (es) Compuestos nuevos para el tratamiento del cáncer
CL2016002879A1 (es) Composiciones farmacéuticas para tratar enfermedades infecciosas
MX2017010341A (es) Terapia para cancer con un parvovirus combinado con bevacizumab.
CL2015003433A1 (es) Derivados de tilosina y método para su preparación
MX2017003469A (es) Inhibidores macrociclicos de cinasa rip2.
UY35695A (es) Composicion para el tratamiento contra el envejecimiento de la piel
AR097111A1 (es) Combinación y método para la administración a un animal
CL2013000332A1 (es) Matriz impregnable de origen vegetal, animal o sintetica que contiene un compuesto antimicrobiano distribuido homogeneamente; procedimiento para impregnar un compuesto en una matriz; uso de dicha matriz para preparar soportes solidos de uso cosmetico, farmaceutico, medico o veterinario.
CR20150641U (es) Composiciones farmacéuticas
CL2013000660A1 (es) Extracto de hemocitos de loco (concholepas concholepas) con actividad antimicrobiana, composicion farmaceutica que comprende dicho extracto; metodo para producir el extracto; uso del extracto porque sirve de aditivo o coadyuvantes para conservar alimentos y evitar su contaminación con microorganismos.